ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.53
1.40%
US Tech 100
17,600.00
1.04%
S&P 500
5,180.74
1.03%
US Dollar vs CAD
1.36715
-0.15%
Bitcoin
63,166.48
0.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. OWC Pharmaceuticals Research Corporation (CE) (OWCP)

  7. OWC Pharmaceuticals Research Corporation (CE) (OWCP) News

OWCP

OWC Pharmaceuticals Rese... (CE) (OWCP)

OWC Pharmaceuticals Research Corporation (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OWCP
DateTimeSourceHeadlineSymbolCompany
06/21/20215:35AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
06/21/20215:32AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/30/20214:08PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
02/25/20213:01PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
12/14/20202:53PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
09/25/20201:30PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
09/04/202011:37AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
09/02/202012:58PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
08/14/20209:22AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
07/27/20203:06PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
07/22/20203:06PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
06/26/20203:07PMEdgar (US Regulatory)Amended Termination of Registration of a Class of Security Under Section 12(g) (15-12g/a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
06/26/20203:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
06/24/20203:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
05/11/20201:47PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/31/20203:07PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/31/20203:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/27/20203:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/18/202010:33AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
03/09/20203:05PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
02/26/20203:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
01/14/20206:09AMInvestorsHub NewsWireEpazz, Inc. (OTC: EPAZ) the Apple Computer of Smart Hemp Farming Conforms More Pre-Orders.USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
01/08/20206:21AMInvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) Confirms Preorders of Smart Hemp Farming SolutionUSOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
12/12/20198:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/26/20193:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/20/20193:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/19/20195:02AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/13/20193:07PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/13/20198:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
11/08/20198:01AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:OWCPOWC Pharmaceuticals Research Corporation (CE)
 Showing the most relevant articles for your search:USOTC:OWCP

Your Recent History

USOTC
INKW
Greene Concepts (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
SFLM
SFLMaven (PK)
USOTC
TGLO
TheGlobe com (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
NASDAQ
MULN
Mullen Automotive
USOTC
MGON
Megola (PK)
USOTC
AFFU
Affluence (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
ALYI
Alternet Systems (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ILST
International Star (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
AHRO
Authentic (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved